Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012
Tue, June 26, 2012
Mon, June 25, 2012

West Announces Completion of Private Placement of Senior Debt Securities


//health-fitness.news-articles.net/content/2012/ .. private-placement-of-senior-debt-securities.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


July 05, 2012 16:30 ET

West Announces Completion of Private Placement of Senior Debt Securities

LIONVILLE, PA--(Marketwire - Jul 5, 2012) -  West Pharmaceutical Services, Inc. (NYSE: [ WST ]) ("West") today announced that it has completed a private placement of $168 million senior unsecured notes (the "Notes") in a private placement exempt from registration under the Securities Act of 1933, as amended. Three series of Notes were issued as follows:

   
Series, coupon, maturity  Principal
   
Series 2012 A, 3.67% due July 5, 2022 $42 million
Series 2012 B, 3.82% due July 5, 2024  $53 million
Series 2012 C, 4.02% due July 5, 2027  $73 million
   

The proceeds from the issuance will reduce indebtedness under West's revolving credit facility that was incurred to finance the purchase of $158.4 million aggregate principal amount of West's 4.00% Convertible Junior Subordinated Debentures due 2047, under a tender offer (the "Tender Offer") that was completed on June 5, 2012.

The weighted average of the coupon interest rates on the Notes is 3.87%. Related interest-rate hedging and transaction costs will increase the annual effective rate of interest to an estimated 4.16% for financial reporting purposes. West will provide a further update of its 2012 financial guidance, including the anticipated effects of the Tender Offer and Notes, in connection with the press release announcing its second-quarter 2012 financial results, which is tentatively scheduled for August 2, 2012.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. West also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at [ www.westpharma.com ].



Publication Contributing Sources